Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

291 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Treatment outcomes of high-dose chemotherapy plus stem cell rescue in high-risk neuroblastoma patients in Thailand.
Suwannaying K, Techavichit P, Komvilaisak P, Laoaroon N, Narkbunnam N, Sanpakit K, Chiengthong K, Chotsampancharoen T, Sathitsamitphong L, Santong C, Seksarn P, Hongeng S, Wiangnon S. Suwannaying K, et al. Among authors: hongeng s. Clin Exp Pediatr. 2022 Sep;65(9):453-458. doi: 10.3345/cep.2022.00437. Epub 2022 May 24. Clin Exp Pediatr. 2022. PMID: 35619231 Free PMC article.
Outcomes of thalassemia patients undergoing hematopoietic stem cell transplantation by using a standard myeloablative versus a novel reduced-toxicity conditioning regimen according to a new risk stratification.
Anurathapan U, Pakakasama S, Mekjaruskul P, Sirachainan N, Songdej D, Chuansumrit A, Charoenkwan P, Jetsrisuparb A, Sanpakit K, Pongtanakul B, Rujkijyanont P, Meekaewkunchorn A, Sruamsiri R, Ungkanont A, Issaragrisil S, Andersson BS, Hongeng S. Anurathapan U, et al. Among authors: hongeng s. Biol Blood Marrow Transplant. 2014 Dec;20(12):2066-71. doi: 10.1016/j.bbmt.2014.07.016. Epub 2014 Jul 23. Biol Blood Marrow Transplant. 2014. PMID: 25064743 Free PMC article.
Hematopoietic stem cell transplantation for homozygous β-thalassemia and β-thalassemia/hemoglobin E patients from haploidentical donors.
Anurathapan U, Hongeng S, Pakakasama S, Sirachainan N, Songdej D, Chuansumrit A, Charoenkwan P, Jetsrisuparb A, Sanpakit K, Rujkijyanont P, Meekaewkunchorn A, Lektrakul Y, Iamsirirak P, Surapolchai P, Satayasai W, Sirireung S, Sruamsiri R, Wahidiyat PA, Ungkanont A, Issaragrisil S, Andersson BS. Anurathapan U, et al. Among authors: hongeng s. Bone Marrow Transplant. 2016 Jun;51(6):813-8. doi: 10.1038/bmt.2016.7. Epub 2016 Feb 15. Bone Marrow Transplant. 2016. PMID: 26878659 Free PMC article.
Clinical outcomes and prognostic factors to predict treatment response in high risk neuroblastoma patients receiving topotecan and cyclophosphamide containing induction regimen: a prospective multicenter study.
Rujkijyanont P, Photia A, Traivaree C, Monsereenusorn C, Anurathapan U, Seksarn P, Sosothikul D, Techavichit P, Sanpakit K, Phuakpet K, Wiangnon S, Chotsampancharoen T, Chainansamit SO, Kanjanapongkul S, Meekaewkunchorn A, Hongeng S. Rujkijyanont P, et al. Among authors: hongeng s. BMC Cancer. 2019 Oct 16;19(1):961. doi: 10.1186/s12885-019-6186-z. BMC Cancer. 2019. PMID: 31619207 Free PMC article.
Hematopoietic Stem Cell Transplantation for Severe Thalassemia Patients from Haploidentical Donors Using a Novel Conditioning Regimen.
Anurathapan U, Hongeng S, Pakakasama S, Songdej D, Sirachainan N, Pongphitcha P, Chuansumrit A, Charoenkwan P, Jetsrisuparb A, Sanpakit K, Rujkijyanont P, Meekaewkunchorn A, Lektrakul Y, Iamsirirak P, Surapolchai P, Sirireung S, Sruamsiri R, Wahidiyat PA, Andersson BS. Anurathapan U, et al. Among authors: hongeng s. Biol Blood Marrow Transplant. 2020 Jun;26(6):1106-1112. doi: 10.1016/j.bbmt.2020.01.002. Epub 2020 Jan 11. Biol Blood Marrow Transplant. 2020. PMID: 31931116 Free article.
Phase II, multi-center, open-label, single-arm clinical trial evaluating the efficacy and safety of Mycophenolate Mofetil in patients with high-grade locally advanced or metastatic osteosarcoma (ESMMO): rationale and design of the ESMMO trial.
Koonrungsesomboon N, Ngamphaiboon N, Townamchai N, Teeyakasem P, Charoentum C, Charoenkwan P, Natesirinilkul R, Sathitsamitphong L, Ativitavas T, Chaiyawat P, Klangjorhor J, Hongeng S, Pruksakorn D. Koonrungsesomboon N, et al. Among authors: hongeng s. BMC Cancer. 2020 Mar 30;20(1):268. doi: 10.1186/s12885-020-06751-2. BMC Cancer. 2020. PMID: 32228535 Free PMC article. Clinical Trial.
Pediatric primary central nervous system tumors registry in Thailand under National Health Security Office schemes.
Pongtanakul B, Sirachainan N, Surapolchai P, Charoenkwan P, Choeyprasert W, Komwilaisak P, Chainansamit SO, Witsanuyothin N, Lertrakul Y, Rujkijyanont P, Kanjanapongkul S, Sosothikul D, Sanpakit K, Chotsampancharoen T, Wangruangsathit S, Thokanit NS, Tabjareon S, Hongeng S. Pongtanakul B, et al. Among authors: hongeng s. J Neurooncol. 2020 Aug;149(1):141-151. doi: 10.1007/s11060-020-03582-w. Epub 2020 Jul 24. J Neurooncol. 2020. PMID: 32710301
Treatment outcomes among high-risk neuroblastoma patients receiving non-immunotherapy regimen: Multicenter study on behalf of the Thai Pediatric Oncology Group.
Suwannaying K, Monsereenusorn C, Rujkijyanont P, Techavichit P, Phuakpet K, Pongphitcha P, Chainansamit SO, Chotsampancharoen T, Winaichatsak A, Traivaree C, Sathitsamitphong L, Kanjanapongkul S, Komvilaisak P, Sanpakit K, Photia A, Seksarn P, Wiangnon S, Hongeng S; Thai Pediatric Oncology Neuroblastoma Working Group. Suwannaying K, et al. Among authors: hongeng s. Pediatr Blood Cancer. 2022 Sep;69(9):e29757. doi: 10.1002/pbc.29757. Epub 2022 May 13. Pediatr Blood Cancer. 2022. PMID: 35560972
291 results